by Donna Vanderpool, MBA, JD Ms. Vanderpool is Vice President, Risk Management, at PRMS, Inc. Innov Clin Neurosci. 2017;14(5–6):31–32 This ongoing column is dedicated to providing information to our readers
by Geeta Shroff, MD Dr. Shroff is Director of Nutech Mediworld in New Delhi, India. Innov Clin Neurosci. 2017;14(3–4):12–16. Funding: No funding was received for the preparation of this article.
by Chad Gwaltney, PhD; James C Mundt, PhD; John H. Greist, MD; Jean Paty, PhD; and Brian Tiplady, PhD Dr. Gwaltney is with Gwaltney Consulting, Westerly, Rhode Island (with ERT
by Katie T.B. Touma, PharmD, BCPP, BCPS; Allysa M. Zoucha, PharmD, BCPP; and Jonathan R. Scarff, MD Drs. Blissit and Zoucha are with William Jennings Bryan Dorn VA Medical Center,
It’s Time for Combination Therapies in Multiple Sclerosis
by Jagannadha Avasarala, MD, PhD Dr. Avasarala is Associate Professor of Neurology, Division of Neurology, Department of Medicine, University of South Carolina School of Medicine, Greenville Health System, Greenville, South
Read More